Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8812367 | 1.00 | APP (0.42) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL6736117 | 0.98 | APP (0.44) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL8620435 | 0.90 | APP (0.46) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL2601699 | 0.79 | PTGS1 (0.41) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL10021960 | 0.79 | APP (0.41) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL28818990 | 0.79 | APP (0.41) | APPEPHX2PTGS1PDE4ALMNA | |
| Sulfuric Acid SCHEMBL28687843 | 0.79 | CA5A (0.40) | FFAR1CPT2TDP1 | |
| SCHEMBL6692218 | 0.79 | APP (0.61) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL922126 | 0.79 | APP (0.61) | APPEPHX2PTGS1PDE4ALMNA | |
| SCHEMBL1270542 | 0.79 | APP (0.61) | APPEPHX2PTGS1PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003106445-A1 | COMPOUNDS AND METHODS FOR CONTROLLING BACTERIAL VIRULENCE | QSI PHARMA A/S (DK) | 2003-12-24 | — | — | WO | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |